FR2362861A1 - Preparations d'haptoglobine fixee - Google Patents

Preparations d'haptoglobine fixee

Info

Publication number
FR2362861A1
FR2362861A1 FR7722068A FR7722068A FR2362861A1 FR 2362861 A1 FR2362861 A1 FR 2362861A1 FR 7722068 A FR7722068 A FR 7722068A FR 7722068 A FR7722068 A FR 7722068A FR 2362861 A1 FR2362861 A1 FR 2362861A1
Authority
FR
France
Prior art keywords
haptoglobin
fixed
preparations
fibrin
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7722068A
Other languages
English (en)
Other versions
FR2362861B1 (fr
Inventor
Satoshi Funakoshi
Takao Domura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of FR2362861A1 publication Critical patent/FR2362861A1/fr
Application granted granted Critical
Publication of FR2362861B1 publication Critical patent/FR2362861B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

Préparations d'haptoglobine fixées sur un support. Ces préparations sont constituées d'haptoglobine active et de fibrine, dans laquelle l'haptoglobine est fixée, ce qui le rend insoluble. La fixation peut se faire par inclusion ou par liaison chimique au moyen d'un réactif bifonctionneL Application à l'absorption et à l'élimination de l'hémoglobine libérée dans le plasma sanguin circulant dans un système à circulation sanguine extracorporelle telle qu'un système coeur-poumon artificiel
FR7722068A 1976-08-27 1977-07-19 Preparations d'haptoglobine fixee Granted FR2362861A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10276376A JPS5329908A (en) 1976-08-27 1976-08-27 Immobilized haptoglobin preparation

Publications (2)

Publication Number Publication Date
FR2362861A1 true FR2362861A1 (fr) 1978-03-24
FR2362861B1 FR2362861B1 (fr) 1980-02-15

Family

ID=14336221

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7722068A Granted FR2362861A1 (fr) 1976-08-27 1977-07-19 Preparations d'haptoglobine fixee

Country Status (12)

Country Link
US (1) US4113853A (fr)
JP (1) JPS5329908A (fr)
BE (1) BE857021A (fr)
CA (1) CA1085291A (fr)
CH (1) CH632930A5 (fr)
DE (1) DE2732437C3 (fr)
ES (1) ES460861A1 (fr)
FR (1) FR2362861A1 (fr)
GB (1) GB1551646A (fr)
LU (1) LU77802A1 (fr)
NL (1) NL176637C (fr)
SE (1) SE446430B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462989A (en) * 1981-05-04 1984-07-31 Evreka, Inc. Method and agents for arresting infection
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
ATE302019T1 (de) * 1997-02-28 2005-09-15 Univ California Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
JP2006516994A (ja) * 2003-01-29 2006-07-13 ノースフィールド ラボラトリーズ、インコーポレイテッド テトラマーの量を低下させた重合ヘモグロビン溶液及び調製するための方法
US20070196810A1 (en) * 2006-01-24 2007-08-23 Northfield Laboratories Inc. Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

Also Published As

Publication number Publication date
CA1085291A (fr) 1980-09-09
DE2732437C3 (de) 1979-09-27
SE7707889L (sv) 1978-02-28
US4113853A (en) 1978-09-12
SE446430B (sv) 1986-09-15
BE857021A (fr) 1977-11-14
LU77802A1 (fr) 1977-10-25
DE2732437B2 (de) 1979-02-01
FR2362861B1 (fr) 1980-02-15
NL176637C (nl) 1985-05-17
ES460861A1 (es) 1978-04-16
CH632930A5 (de) 1982-11-15
NL176637B (nl) 1984-12-17
JPS5329908A (en) 1978-03-20
GB1551646A (en) 1979-08-30
DE2732437A1 (de) 1978-03-02
NL7708024A (nl) 1978-03-01
JPS5523806B2 (fr) 1980-06-25

Similar Documents

Publication Publication Date Title
ATE63694T1 (de) Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung.
FR2350107A1 (fr) Appareil de reglage de la concentration du glucose dans le sang
IT8348129A0 (it) Glucosio nel soggetto diabetico apparecchio che infonde insulina o sulla base di determinazioni di concentrazioni di glucosio ottenute senza bisogno di prelievi del sangue del paziente
ATE59146T1 (de) Geraet zur bestrahlung von blutteilen.
ATE60235T1 (de) Geraet zur aufnahme und reinfusion von blut.
PT920322E (pt) Tratamento de doencas autoimunes
ATE77056T1 (de) Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
ATE42456T1 (de) Blutentnahme-einheit.
DE68915715D1 (de) Membran-Blutoxygenator.
SE7601540L (sv) Medel for faststellande av blod och hemoglobin i biologiska emnen
ATE252350T1 (de) Gerät zum behandeln von herzstillständen
IT8719834A0 (it) Procedimento e dispositivo per la circolazioe extracorporea del sangue e per assistenza cardiovascolare.
IT7928370A0 (it) Procedimento per determinare l'emoglobina glicosilata in campioni di sangue.
ATE28571T1 (de) Schlauchsystem zur behandlung von blut ausserhalb des koerpers and aehnlichen leichtverderblichen fluessigkeiten.
SE8505047D0 (sv) Fettemulsion
DE3788370D1 (de) Dopplersystem zur Bluttströmungsmessung während eines Herz-Lungen-Nebenschlusses und Kammerunterstützung.
FR2425864A1 (fr) Dispositif medical pour appareil de diffusion et notamment pour appareil de dialyse ou analogue
EP0256415A3 (fr) Système d'analyse
Baskin et al. Erythropoietin-associated hypertension
DK458682A (da) Fremgangsmaade og reagens til bestemmelse af glucoliseret haemoglobin
SE8002469L (sv) Forfarande och reagens for bestemning av hemoglobinhalten i blod
DE3769830D1 (de) Kraftfrei einzufuehrender anschluss fuer ein system zur behandlung eines patienten durch photoaktivierung.
Guarino et al. An artificial kidney—a simplified apparatus
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
ATE123310T1 (de) Monoklonale antikörper gegen nicht-a 1c glykosyliertes hämoglobin.

Legal Events

Date Code Title Description
ST Notification of lapse